diabetes and more
Follow
Find
25.6K views | +55 today
Scooped by Ellen H Ullman, MSW
onto diabetes and more
Scoop.it!

JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies

JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
PR Newswire

NEW YORK, April 24, 2012

--Novel Transmitter Will Simplify Artificial Pancreas Research by Eliminating a Separate CGM component--

NEW YORK, April 24, 2012 /PRNewswire-USNewswire/ -- JDRF, the leading global organization focused on type 1 diabetes (T1D) research, announced today that it has partnered with Dexcom, Inc. (Nasdaq: DXCM), a San Diego, CA-based medical device company focused on developing and marketing continuous glucose monitoring (CGM) systems. The goal of the partnership is to accelerate the development of a novel wireless "smart transmitter" that would allow a CGM system to communicate directly with an artificial pancreas control device currently being used for research studies, instead of only with a CGM receiver.

JDRF will provide Dexcom up to $500,000 over 12 months in milestone-based funding to complete the development, testing, and manufacturing of a custom "smart transmitter" prototype, which will be used for studies within JDRF's Artificial Pancreas Project academic research consortium. The direct communication capability enabled by the smart transmitter will be an important feature for artificial pancreas trials in outpatient (real-world) settings, as it would eliminate the need for a trial participant to carry multiple devices all wired together while testing an artificial pancreas system's ability to manage glucose levels.

People with T1D are burdened with constantly having to determine th

Read more: http://www.digitaljournal.com/pr/677680#ixzz1sxXIaEyK

more...
No comment yet.
diabetes and more
Important news for those concerned with all types of diabetes, associated autoimmune diseases, & health
Your new post is loading...
Scooped by Ellen H Ullman, MSW
Scoop.it!

Diabetes Complications Show Sharp Decline, Report Finds - NYTimes.com

more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Patients Often Win If They Appeal A Denied Health Claim

Patients Often Win If They Appeal A Denied Health Claim | diabetes and more | Scoop.it
Obamacare set national rules for appealing a denied health claim — a process that used to vary by employer and state. Consumers should appeal more often, advocates say. Half the time, they'll win.
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

UB Medical Students Support Teen Diabetes Patients, Gain Experience - UB School of Medicine and Biomedical Sciences

UB Medical Students Support Teen Diabetes Patients, Gain Experience - UB School of Medicine and Biomedical Sciences | diabetes and more | Scoop.it
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Patterns of Obesity Development before the Diagnosis of Type 2 Diabetes: The Whitehall II Cohort Study

Patterns of Obesity Development before the Diagnosis of Type 2 Diabetes: The Whitehall II Cohort Study | diabetes and more | Scoop.it
PLOS Medicine is an open-access, peer-reviewed medical journal that publishes outstanding human studies that substantially enhance the understanding of human health and disease.
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Insurers Target Glut Of New Diabetes Patients

Insurers Target Glut Of New Diabetes Patients | diabetes and more | Scoop.it
Insurance companies are taking an aggressive approach toward a glut of new diabetes patients who now have coverage under the Affordable Care Act.
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

MicroBiome Therapeutics LLC Clinical Trial Data For NM504 In Type 2 Diabetes Has Been Accepted For Presentation At ICE/ENDO 2014

BROOMFIELD, Colo., April 8, 2014 /PRNewswire/ -- MicroBiome TherapeuticsTM LLC, today announced that data from the company's clinical trial of
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Mechanobiology: Enzyme micropump autonomously delivers insulin in response to glucose levels

Mechanobiology: Enzyme micropump autonomously delivers insulin in response to glucose levels | diabetes and more | Scoop.it
(Phys.org) —For next-generation smart devices, autonomy is key. These devices will be able to power themselves, independently respond to stimuli, and perform different kinds of work, all without human intervention. With these abilities, smart devices could potentially have very wide-reaching implications.
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

The Cost of Staying Alive with Diabetes: A Response to the New York Times

The Cost of Staying Alive with Diabetes: A Response to the New York Times | diabetes and more | Scoop.it
Like many with diabetes, I had a complicated reaction to the recent story in the New York Times, “Even Small Medical Advances Can Mean Big Jumps in Bills,”
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Arizona Reinstates Medicaid Insulin Pump Coverage: A Triumph in Patient Advocacy!

Arizona Reinstates Medicaid Insulin Pump Coverage: A Triumph in Patient Advocacy! | diabetes and more | Scoop.it
The Arizona State Legislature has approved the restoration of insulin pump coverage for adults in the state's Medicaid program! This is partially thanks to a patient-led Twitter campaign
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

MannKind Rival, Also Developing Inhaled Insulin Device, Files $75M IPO

MannKind Rival, Also Developing Inhaled Insulin Device, Files $75M IPO | diabetes and more | Scoop.it
Adam Feuerstein's biotechnology blog, Biotech Beat, features Adam's opinion and analysis on an array of biotech and pharmaceutical stocks and companies.
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Lilly slapped with $3 billion penalty over diabetes drug, cancer risk

Lilly slapped with $3 billion penalty over diabetes drug, cancer risk | diabetes and more | Scoop.it
(April 8, 2014) – A federal jury ordered Eli Lilly and Co. and Takeda Pharmaceutical Co. to pay $9 billion after jurors said the companies hid the cancer risks of their Actos diabetes medicine. As part of the ruling, Indianapolis-based Lilly was
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Continuous glucose monitoring in children: an interview with Terrance Gregg, CEO of Dexcom

Continuous glucose monitoring in children: an interview with Terrance Gregg, CEO of Dexcom | diabetes and more | Scoop.it
Scientific research into CGM-like sensors goes back more than 40 years. I was working with the first company to begin commercial development, MiniMed, back in 1992 when the science was really beginning to percolate. In 1999 the FDA approved the first CGM device for use in the United States.
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Stem-cell row 'a blow for science'

Stem-cell row 'a blow for science' | diabetes and more | Scoop.it
National The finding that a lead researcher falsified data in a widely heralded stem-cell research paper is a setback for Japan's efforts to promote its advanced research, but also ...
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Xeris Pharmaceuticals Receives U.S. Patent for its Novel, Stable Non-Aqueous Glucagon Formulations

Xeris Pharmaceuticals Receives U.S. Patent for its Novel, Stable Non-Aqueous Glucagon Formulations | diabetes and more | Scoop.it
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

12 OYS: Other-than-honorable vet says VA cutting insulin supply after 15 years

12 OYS: Other-than-honorable vet says VA cutting insulin supply after 15 years | diabetes and more | Scoop.it
He served his country in Vietnam. But 15 years after he started receiving benefits, a local veteran is accusing the VA of cutting off his insulin supply.
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Diabetes prevention scoring system improved accuracy of type 1 risk classification | Endocrinology

Diabetes prevention scoring system improved accuracy of type 1 risk classification | Endocrinology | diabetes and more | Scoop.it
Endocrinology | Physicians can more accurately classify patients at risk for type 1 diabetes with the help of a scoring system that improves identification between high-risk normoglycemic and low-risk dysglycemic individuals, according to research published in Diabetes Care.
“The findings indicate that a reliance upon dysglycemia as a demarcation of risk in autoantibody-positive populations could result
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Lakewood Ranch Cinemas apologizes after taking supplies from diabetic | Lakewood Ranch Herald | Bradenton Herald

Lakewood Ranch Cinemas apologizes after taking supplies from diabetic | Lakewood Ranch Herald | Bradenton Herald | diabetes and more | Scoop.it
A 16-year-old diabetic boy was not allowed to bring in his special snacks to an afternoon showing of Divergent. The manager said outside food and drink is banned.
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Adocia reports positive results from phase IIa clinical study of ultra-fast acting BioChaperone(R) Lispro | Proteins and Peptides | News Channels

Adocia reports positive results from phase IIa clinical study of ultra-fast acting BioChaperone(R) Lispro
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Telcare Joins Verizon Partner Program, Offers Award-winning Diabetes Monitoring System

Telcare, Inc., an award-winning medical device and IT company, is now offering a revolutionary diabetes management system to business owners and their
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Common Tests May Miss Pediatric Diabetic Neuropathy

Noninvasive methods for screening pediatric patients with type 1 diabetes for peripheral diabetic nephropathy are not very sensitive, according to a new review.
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Trends in the Prevalence of Ketoacidosis at Diabetes Diagnosis: The SEARCH for Diabetes in Youth Study

more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Stine enjoying happy marriage at Novo Nordisk

Stine enjoying happy marriage at Novo Nordisk | diabetes and more | Scoop.it
Former Lions' ballplayer lives and loves his job.
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

American Journal of Managed Care to Host Joslin's Chief Medical Officer, Triathlete with Type 1 Diabetes, at Princeton Event

American Journal of Managed Care to Host Joslin's Chief Medical Officer, Triathlete with Type 1 Diabetes, at Princeton Event | diabetes and more | Scoop.it
PLAINSBORO, N.J. (PRWEB) April 09, 2014 -- Ironman triathlete Jay Hewitt will speak tomorrow at the evening reception of Patient-Centered Diabetes Care: Putting Theory into Practice, which is bringing leaders in diabetes healthcare delivery to the Princeton Marriott at Forrestal. On Friday, Dr. Robert Gabbay, chief medical officer of the Joslin Diabetes Center, will offer a keynote address.
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

MannKind Says FDA Delays Decision On Inhaled Insulin Treatment

MannKind Says FDA Delays Decision On Inhaled Insulin Treatment | diabetes and more | Scoop.it
MannKind Corp said the U.S. Food and Drug Administration extended the review date of its inhaled insulin treatment by three months, sending the company's shares down as much as 22 percent before the bell.
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

FDA Wants YOUR Opinion on Glucose Meter & Test Strip Accuracy

FDA Wants YOUR Opinion on Glucose Meter & Test Strip Accuracy | diabetes and more | Scoop.it
Listen up, Friends: it's officially crunch time to let the decision-makers at FDA know what we want to see in terms of accurate glucose meters and strips! Seriously, this is the first time in more than a decade that the regulatory agency's updated these rules on accuracy, and it's the first time in history the…
more...
No comment yet.